+29.1%
MRNA vs ALL
+150.1%
-120.9%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ALL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.7% | +1.5% | +0.5% |
| 7D | -8.2% | -4.3% | -3.9% | -9.6% |
| 30D | +125.6% | -3.6% | +129.1% | +123.2% |
| 3M | +197.1% | +13.2% | +183.9% | +205.8% |
| 6M | +148.5% | +22.5% | +126.0% | +161.5% |
| YTD | +363.3% | +22.7% | +340.5% | +389.5% |
| 1Y | +462.0% | +28.3% | +433.7% | +497.0% |
| All | +29.1% | +150.1% | -120.9% | +69.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ALL.
Daily Out/Under-Performance
Portfolio return minus ALL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ALL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling